Akt activation protects rat liver from ischemia/reperfusion injury. 2004

Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

BACKGROUND Apoptosis as well as necrosis may play an important role in hepatic ischemia/reperfusion (I/R) injury. Akt, a serine-threonine protein kinase, is known to promote cell survival. We investigated whether gene transfer of constitutively active or dominant negative Akt could affect hepatic I/R injury. METHODS Hepatic I/R injury was induced in rats by Pringle's maneuver for 20 min followed by reperfusion. Adenoviruses encoding a constitutively active form of Akt (myrAkt), a dominant negative form of Akt (dnAkt), or beta-galactosidase (LacZ) were injected through the tail vein 72 h before hepatic I/R. RESULTS Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) staining demonstrated a significant increase in the positive cells 240 min after reperfusion. Immunoblotting with phospho-Akt antibody showed phosphorylation of Akt from 90 to 180 min after reperfusion. The expression of myrAkt reduced the number of TUNEL-positive cells and hepatic necrosis around the central veins in the liver after reperfusion. This expression also significantly inhibited the increase in serum alanine aminotransferase (297 +/- 131 IU/L, P < 0.05) 120 min after I/R, compared with increases in uninfected (1761 +/- 671 IU/L), LacZ adenovirus (1528 +/- 671 IU/L)-, and dnAkt adenovirus (1342 +/- 485 IU/L)-infected rats. MyrAkt expression phosphorylated Bad and inhibited the release of cytochrome-c after reperfusion. No difference in nuclear translocation of nuclear factor (NF)-kappaB, p65 was seen among the three groups of rats, however. CONCLUSIONS Adenoviral gene transfer of myrAkt could inhibit apoptotic cell death and subsequent hepatic I/R injury in the rat, through Bad, not NF-kappaB.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses

Related Publications

Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
February 2006, Hepatology research : the official journal of the Japan Society of Hepatology,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
July 2014, Annals of surgery,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
May 2018, Circulation research,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
March 2018, Canadian journal of physiology and pharmacology,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
August 2003, Transplantation proceedings,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
June 2010, Acta pharmacologica Sinica,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
May 2004, Hepatobiliary & pancreatic diseases international : HBPD INT,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
June 2020, International immunopharmacology,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
July 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Nobuko Harada, and Etsuro Hatano, and Naoki Koizumi, and Takashi Nitta, and Masanori Yoshida, and Naritaka Yamamoto, and David A Brenner, and Yoshio Yamaoka
May 2000, European journal of pharmacology,
Copied contents to your clipboard!